메뉴 건너뛰기




Volumn 5, Issue 4, 2006, Pages 331-344

Tuberculosis: Current treatment and new drug development

Author keywords

Antibiotic resistance; Drug development; Mycobacteria; Mycobacterial cell wall; Mycobacterium tuberculosis; TB

Indexed keywords

1 (6 BROMO 2 METHOXY 3 QUINOLINYL) 4 DIMETHYLAMINO 2 (1 NAPHTHYL) 1 PHENYL 2 BUTANOL; 4 NITROIMIDAZOLE; 6,7 DIHYDRO 2 NITRO 6 (4 TRIFLUOROMETHOXYBENZYLOXY) 5H IMIDAZO[2,1 B][1,3]OXAZINE; AMIKACIN; AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; CAPREOMYCIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; GATIFLOXACIN; IMIDAZOPYRIDINE DERIVATIVE; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; LINEZOLID; METRONIDAZOLE; MOXIFLOXACIN; NATURAL PRODUCT; OXAZOLIDINONE DERIVATIVE; PURINE DERIVATIVE; PYRAZINAMIDE; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOXALINE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT; UNINDEXED DRUG;

EID: 33750077287     PISSN: 18715214     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152106778520433     Document Type: Review
Times cited : (15)

References (114)
  • 5
    • 0042352454 scopus 로고    scopus 로고
    • World Health Organization
    • World Health Organization. Stop TB Annual Report. 2001.
    • (2001) Stop TB Annual Report


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.